Anxin Pharmaceutical

Zhejiang Anxin Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. Established in 2004 and headquartered in Linhai, Zhejiang, the company has built a strong reputation in the Central Nervous System (CNS) therapeutic area. Its core product portfolio includes widely used medications such as Gabapentin, Pregabalin, and various Valproate salts. Anxin's manufacturing facilities are designed to meet global regulatory standards, holding certifications from the US FDA, EDQM, and China's NMPA. The company operates as both a generic drug manufacturer and a strategic partner for global pharmaceutical firms through its CDMO services. Their business model encompasses both domestic sales within China and significant export operations to global markets, particularly the United States and Europe.